202 related articles for article (PubMed ID: 33948356)
1. Cordycepin inhibits the proliferation of malignant peripheral nerve sheath tumor cells through the p53/Sp1/tubulin pathway.
Lee MJ; Lee JC; Hsieh JH; Lin MY; Shih IA; You HL; Wang K
Am J Cancer Res; 2021; 11(4):1247-1266. PubMed ID: 33948356
[TBL] [Abstract][Full Text] [Related]
2. A novel HDAC11 inhibitor potentiates the tumoricidal effects of cordycepin against malignant peripheral nerve sheath tumor through the Hippo signaling pathway.
Huang PY; Shih IA; Liao YC; You HL; Lee MJ
Am J Cancer Res; 2022; 12(2):873-892. PubMed ID: 35261809
[TBL] [Abstract][Full Text] [Related]
3. Calebin-A induced death of malignant peripheral nerve sheath tumor cells by activation of histone acetyltransferase.
Lee MJ; Tsai YJ; Lin MY; You HL; Kalyanam N; Ho CT; Pan MH
Phytomedicine; 2019 Apr; 57():377-384. PubMed ID: 30831486
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
5. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
Friedrich RE; Keiner D; Hagel C
Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth.
Yang K; Guo W; Ren T; Huang Y; Han Y; Zhang H; Zhang J
J Exp Clin Cancer Res; 2019 May; 38(1):185. PubMed ID: 31053152
[TBL] [Abstract][Full Text] [Related]
7. Plexiform neurofibroma with and without associated malignant peripheral nerve sheath tumor: a clinicopathologic and immunohistochemical analysis of 54 cases.
McCarron KF; Goldblum JR
Mod Pathol; 1998 Jul; 11(7):612-7. PubMed ID: 9688181
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.
Linke C; Wösle M; Harder A
BMC Cancer; 2020 Sep; 20(1):896. PubMed ID: 32948135
[TBL] [Abstract][Full Text] [Related]
9. CD44 and p53 immunoexpression patterns in NF1 neoplasms - indicators of malignancy and infiltration.
Riddle ND; Gorden L; Rojiani MV; Hakam A; Rojiani AM
Int J Clin Exp Pathol; 2010 Jun; 3(5):515-21. PubMed ID: 20606732
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours.
Kindblom LG; Ahldén M; Meis-Kindblom JM; Stenman G
Virchows Arch; 1995; 427(1):19-26. PubMed ID: 7551341
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
Friedrich RE; Beer C; Glatzel M; Hagel C
Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
[TBL] [Abstract][Full Text] [Related]
12. Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors.
Chau V; Lim SK; Mo W; Liu C; Patel AJ; McKay RM; Wei S; Posner BA; De Brabander JK; Williams NS; Parada LF; Le LQ
Cancer Res; 2014 Jan; 74(2):586-97. PubMed ID: 24285727
[TBL] [Abstract][Full Text] [Related]
13. Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.
Amirnasr A; Verdijk RM; van Kuijk PF; Taal W; Sleijfer S; Wiemer EAC
PLoS One; 2017; 12(8):e0183155. PubMed ID: 28813519
[TBL] [Abstract][Full Text] [Related]
14. Combined Targeting of AKT and mTOR Inhibits Proliferation of Human NF1-Associated Malignant Peripheral Nerve Sheath Tumour Cells In Vitro but not in a Xenograft Mouse Model In Vivo.
Schulte A; Ewald F; Spyra M; Smit DJ; Jiang W; Salamon J; Jücker M; Mautner VF
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102484
[TBL] [Abstract][Full Text] [Related]
15. Delayed rectifier K currents in NF1 Schwann cells. Pharmacological block inhibits proliferation.
Fieber LA; González DM; Wallace MR; Muir D
Neurobiol Dis; 2003 Jul; 13(2):136-46. PubMed ID: 12828937
[TBL] [Abstract][Full Text] [Related]
16. Cordycepin enhances anti-tumor immunity in colon cancer by inhibiting phagocytosis immune checkpoint CD47 expression.
Deng Q; Li X; Fang C; Li X; Zhang J; Xi Q; Li Y; Zhang R
Int Immunopharmacol; 2022 Jun; 107():108695. PubMed ID: 35305385
[TBL] [Abstract][Full Text] [Related]
17. Malignant peripheral nerve sheath tumor: a comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions.
Zhou H; Coffin CM; Perkins SL; Tripp SR; Liew M; Viskochil DH
Am J Surg Pathol; 2003 Oct; 27(10):1337-45. PubMed ID: 14508395
[TBL] [Abstract][Full Text] [Related]
18. Doxycycline potentiates antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy in malignant peripheral nerve sheath tumor cells.
Lee MJ; Hung SH; Huang MC; Tsai T; Chen CT
PLoS One; 2017; 12(5):e0178493. PubMed ID: 28558025
[TBL] [Abstract][Full Text] [Related]
19. MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors.
Holtkamp N; Atallah I; Okuducu AF; Mucha J; Hartmann C; Mautner VF; Friedrich RE; Mawrin C; von Deimling A
Neoplasia; 2007 Aug; 9(8):671-7. PubMed ID: 17786186
[TBL] [Abstract][Full Text] [Related]
20. Intervention in genotoxic stress-induced senescence by cordycepin through activation of eIF2α and suppression of Sp1.
Gu L; Johno H; Nakajima S; Yoshitomi T; Takahashi S; Kitamura M
Toxicol Sci; 2013 Aug; 134(2):345-54. PubMed ID: 23690541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
